Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

503
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
503
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.0K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

541
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
541
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

524
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

379
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.

Therapeutic advances in gastroenterology·2026
Same author

Concomitant use of risankizumab in moderate-to-severe psoriasis induced by ofatumumab in a patient with relapsing-remitting multiple sclerosis.

Medicina clinica·2026
Same author

Anifrolumab for refractory lupus panniculitis: Sustained remission in a long-standing case.

Medicina clinica·2026
Same author

Multisite Atherosclerosis and SCORE2-Based Risk Stratification in Psoriatic Arthritis: A Phenotype-Dependent Role of Vascular Territories.

Biomedicines·2026
Same author

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026
Same author

ACOX1 Gain-of-Function and De Novo ROBO1 Variant in ACOX1-sEDD.

Pediatric dermatology·2026

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K

Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.

Anna López-Ferrer1,2,3, Álvaro González-Cantero4,5, Ana Gutiérrez-Casbas6,7,8

  • 1Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90. Block A, 5th Floor, Module 3, 08041, Barcelona, Spain. alopezfe@santpau.cat.

Dermatology and Therapy
|April 18, 2026
PubMed
Summary
This summary is machine-generated.

Psoriasis patients often have undiagnosed comorbidities. New algorithms streamline referrals between specialists, improving early detection and coordinated care for better patient outcomes.

Keywords:
Clinical algorithmClinical decision-makingComorbiditiesMultidisciplinary managementPsoriasisReferral pathways

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.7K
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

927

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.7K
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

927

Area of Science:

  • Dermatology
  • Internal Medicine
  • Public Health

Background:

  • Psoriasis is a systemic inflammatory disease associated with numerous comorbidities.
  • Fragmented care contributes to underdiagnosis and undertreatment of these comorbidities, worsening patient outcomes and quality of life.

Purpose of the Study:

  • To develop screening algorithms and multidisciplinary referral criteria for early detection and coordinated management of psoriatic comorbidities.
  • To reduce diagnostic delays and improve the quality of life for psoriasis patients.

Main Methods:

  • A three-phase methodology involving a literature review, focus groups, and a nominal group session.
  • Guidance and oversight provided by a multidisciplinary scientific committee.

Main Results:

  • Development of five multidisciplinary algorithms for optimizing referrals from dermatology to rheumatology, hepatology, gastroenterology, endocrinology, and psychology.
  • Algorithms integrate clinical criteria, laboratory thresholds, and referral guidance for standardized screening and timely referrals.

Conclusions:

  • Structured decision-making algorithms can reduce diagnostic delays and enhance cross-specialty collaboration in psoriasis care.
  • These tools offer a practical framework for early identification and coordinated management of comorbidities, potentially applicable globally.